What is Inhibrx Biosciences, Inc.'s prepaid & other current?

Inhibrx Biosciences, Inc. (INBX) reported prepaid & other current of $9.5M in Q1 2026.

How has Inhibrx Biosciences, Inc.'s prepaid & other current changed year-over-year?

Inhibrx Biosciences, Inc.'s prepaid & other current increased by 42.8% year-over-year, from $6.65M to $9.5M.

What does prepaid & other current mean?

Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Inhibrx Biosciences, Inc. INBX Prepaid & Other Current

Prepaid & Other Current at other companies

Rogers CorporationROG

$15.4M-2.5%

Gilead SciencesGILD

$4.34B+53.5%

ArriVent BioPharma, Inc.AVBP

$22.32M+130%

ImmunomeIMNM

$11.62M+100%

Replimune GroupREPL

$8.26M+3.6%

IDEAYA Biosciences, Inc.IDYA

$18.35M+19.4%

Other financials

Income statement

See full

Revenue--100%

Operating income-$30.9M+27.9%

Net income-$33.4M+22.8%

EPS (diluted)-$2.15+23.2%

Balance sheet

See full

Cash & equivalents$161.7M-25.3%

Total debt$180.9M+69.8%

Total equity-$21.0M-122%

Total assets$184.0M-24.2%

Cash flow

See full

Operating cash flow-$38.0M-5.9%

CapEx--100%

Free cash flow-$38.0M-5.9%

Valuation

See full

Market cap$1.4B+546%

Enterprise value$1.42B+1,233%

P/S1,073.7×-280×

Profitability

See full

Operating margin-10,386.5%-5,025pp

Net margin-10,773.5%-878,492pp

FCF margin-9,986.5%-4,727pp

Returns & leverage

See full

Return on equity-197.8%-2,158pp

Debt / equity13.4×+13.3×

Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s prepaid & other current?: Inhibrx Biosciences, Inc. (INBX) reported prepaid & other current of $9.5M in Q1 2026.
How has Inhibrx Biosciences, Inc.'s prepaid & other current changed year-over-year?: Inhibrx Biosciences, Inc.'s prepaid & other current increased by 42.8% year-over-year, from $6.65M to $9.5M.
What does prepaid & other current mean?: Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.